CV vs DD · rev $3.5M vs P/E 127, rev $12.39B
CapsoVision, Inc. Common Stock (CV) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
CV currently screens at market cap $359.2M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the CV and DD stock pages for the full models.
Not investment advice.